Omeros (OMER) Earnings Date & Reports

Omeros Corp is an inventive, commercial-stage biotechnology company that discovers and develops first-in-class protein and small-molecule therapeutics for large-market and orphan indications, with particular emphasis on complement-mediated diseases, cancers, and addictive or compulsive disorders... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

OMER is expected to report earnings to rise 5.54% to -25 cents per share on August 12

Q2'26

Est.

$-0.25

Q1'26

Missed

by $0.12

Q4'25

Beat

by $3.66

Q3'25

Beat

by $0.11

Q2'25

Beat

by $0.03

The last earnings report on May 13 showed earnings per share of -23 cents, missing the estimate of -11 cents. With 1.70M shares outstanding, the current market capitalization sits at 747.28M.

View a ticker or compare two or three

Compare

OMER

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for OMER